Cabaletta Bio, Inc.
CABA
$1.21
$0.054.31%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -115.86M | -104.16M | -89.98M | -76.87M | -67.68M |
| Total Depreciation and Amortization | 1.71M | 1.58M | 1.51M | 1.45M | 1.43M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 24.32M | 21.65M | 17.60M | 14.37M | 12.60M |
| Change in Net Operating Assets | 1.61M | -609.00K | -2.96M | -3.89M | 101.00K |
| Cash from Operations | -88.22M | -81.55M | -73.83M | -64.93M | -53.55M |
| Capital Expenditure | -2.21M | -2.02M | -1.83M | -1.12M | -687.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 49.50M | 38.32M | 25.82M | -46.76M | -21.76M |
| Cash from Investing | 47.29M | 36.30M | 23.99M | -47.88M | -22.45M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -897.00K | -- | -- | -- | -- |
| Issuance of Common Stock | 12.57M | 100.35M | 100.38M | 194.03M | 187.63M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 232.00K | 0.00 |
| Cash from Financing | 11.68M | 100.35M | 100.38M | 194.26M | 187.63M |
| Foreign Exchange rate Adjustments | -20.00K | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -29.28M | 55.11M | 50.54M | 81.45M | 111.63M |